US 9,801,884 B2 · Nucleotide analogs

Abstract

Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.

Claims11

Dependent claims

A compound selected from the group consisting of:

Dependencies are inferred from the claim text.

Facts

Application

15/171,935Filed 2 Jun 2016 · continuation

Priority

15 Sep 2014

Published

US 2017/0037068 A19 Feb 2017

Granted

31 Oct 2017

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

A61K 31/522
Purines, e.g. adenine: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 8/24
Containing inorganic ingredients: phosphorous; Compounds thereof
A61K 31/00
Medicinal preparations containing organic active ingredients
A61P 15/00
Drugs for genital or sexual disorders

Family

Application62/050,624Us provisional application · filed 15 Sep 2014

Application14/854,897Parent of this continuation · filed 15 Sep 2015

US 2017/0037068 A1Pre-grant publication · published 9 Feb 2017

US 9,493,493 B2Parent of this continuation

US 2016/0083407 A1Published application

US 9,801,884 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.

Nucleotide analogs

Life of this patent

Abstract

Claims11

Nucleotide analogs

Life of this patent

Abstract

Claims11